LEGAL LESSONS: Cellulitis

Cellulitis is common, but the harder problem is deciding when erythema is infection and when it is pseudocellulitis. Initial outpatient treatment still fails in about 1 in 5 cases, while mortality is low enough that well-appearing patients with good return precautions can often go home on oral antibiotics.

Cellulitis Diagnosis and Disposition

• Pseudocellulitis look-alikes: Venous stasis dermatitis, lymphedema, DVT, gout, and contact dermatitis commonly mimic cellulitis, and one admitted cohort found a 30% misdiagnosis rate.
• Failure to diagnose risk: The bigger medicolegal hazard is missing true infection rather than overtreating pseudocellulitis, because diagnostic error matters when it departs from the standard of care.
• Outpatient failure rate: Even correctly diagnosed cellulitis has a meaningful early relapse rate, with oral antibiotic treatment failing in roughly 21% of discharged patients. We get into the return-precaution wording in the episode.
• High-risk failure features: Fever at triage, chronic edema or leg ulcers, prior cellulitis in the same area, and infection at a wound site all raise the odds of outpatient treatment failure.
• Admission decision frame: IDSA flags systemic signs, altered mental status, hemodynamic instability, deep infection concern, severe immunocompromise, and failed outpatient therapy as reasons to consider IV therapy or admission.
• Low mortality perspective: Cellulitis mortality is very low, so a well-appearing patient who understands follow-up and return instructions can often be managed safely with oral antibiotics.

Medicolegal Lessons From the Case

• Atypical first presentation: A blanching, ill-defined, non-tender erythematous thigh lesion without fluctuance or crepitus was initially labeled a drug reaction, then returned days later as septic group B strep cellulitis.
• Margin marking myth: Drawing a line around erythema is common practice, but there is no good evidence that border tracking improves outcomes or safely guides return decisions.
• Causation versus negligence: A bad outcome months later does not automatically make the index visit malpractice; the key legal question is whether the initial assessment violated an actual standard of care.
• Discussing expected failure: Because cellulitis treatment failure is common, risk management starts with explicitly warning patients that worsening can happen despite appropriate therapy and requires prompt reassessment.
• Settlement pressure factors: Venue, community dynamics, and jury risk can drive settlement decisions even when causation feels tenuous. We walk through that courtroom reality in the chapter.

References:

1.) Weng QY, Raff AB, Cohen JM, et al. Costs and Consequences Associated With Misdiagnosed Lower Extremity Cellulitis. JAMA Dermatol. 2017;153(2):141–146. doi:10.1001/jamadermatol.2016.3816

2.) Peterson D, et al. Predictors of failure of empiric outpatient antibiotic therapy in emergency department patients with uncomplicated cellulitis. Acad Emerg Med. 2014 May;21(5):526-31. doi: 10.1111/acem.12371. PMID: 24842503.

3.) Haran JP, Wilsterman E, Zeoli T, Goulding M, McLendon E, Clark MA. Deviating from IDSA treatment guidelines for non-purulent skin infections increases the risk of treatment failure in emergency department patients. Epidemiol Infect. 2018 Dec 5;147:1-7. doi: 10.1017/S0950268818003291. Epub ahead of print. PMID: 30516120. 

4.) Gunderson CG, Cherry BM, Fisher A. Do Patients with Cellulitis Need to be Hospitalized? A Systematic Review and Meta-analysis of Mortality Rates of Inpatients with Cellulitis. J Gen Intern Med. 2018 Sep;33(9):1553-1560. doi: 10.1007/s11606-018-4546-z. Epub 2018 Jul 18. PMID: 30022408.